Suppr超能文献

Cox-2等位基因变异对非裔美国人结肠直肠腺瘤发生风险的保护作用。

Protective effect of Cox-2 allelic variants on risk of colorectal adenoma development in African Americans.

作者信息

Ashktorab Hassan, Tsang Shirley, Luke Brian, Sun Zhonghe, Adam-Campbell Lucile, Kwagyan John, Poirier Richard, Akter Shahina, Akhgar Ahmad, Smoot Duane, Munroe David J, Ali Iqbal Unnisa

机构信息

Department of Medicine and Cancer Center, Howard University College of Medicine, Washington, D.C., USA.

出版信息

Anticancer Res. 2008 Sep-Oct;28(5B):3119-23.

Abstract

BACKGROUND

Recent evidence indicates that single nucleotide polymorphisms (SNPs) in the Cox-2 gene may modulate the risk of colorectal adenoma development.

PATIENTS AND METHODS

We explored possible associations between Cox-2 polymorphisms and risk of adenoma development in an African American case-control study comprising 72 cases of advanced adenomas and 146 polyp-free controls. An exhaustive approach of genotyping 13 haplotype-tagging SNPs (ht SNPs) distributed over the entire COX-2 gene was used.

RESULTS

Statistically significant inverse associations were observed between the heterozygous genotypes at the 5229 G>T polymorphism in intron 5 [odds ratio (OR)=0.42; confidence interval (CI)=0.19-0.92; p=0.03] and at the 10935 A>G polymorphism in the 3' flanking region downstream from the poly A signals (OR=0.39; CI=0.18-0.83;p=0.01) and the risk for colorectal adenoma development.

CONCLUSION

The data from our pilot study suggest that allelic variants of the COX-2 gene significantly influence the risk of adenoma development in the African American population.

摘要

背景

最近的证据表明,Cox-2基因中的单核苷酸多态性(SNP)可能会调节结直肠腺瘤发生的风险。

患者与方法

在一项非裔美国人病例对照研究中,我们探讨了Cox-2基因多态性与腺瘤发生风险之间的可能关联,该研究包括72例晚期腺瘤患者和146例无息肉对照者。采用了一种详尽的方法,对分布在整个COX-2基因上的13个单倍型标签SNP(htSNP)进行基因分型。

结果

在内含子5中5229G>T多态性的杂合基因型[比值比(OR)=0.42;置信区间(CI)=0.19 - 0.92;p = 0.03]以及聚腺苷酸信号下游3'侧翼区域中10935A>G多态性(OR = 0.39;CI = 0.18 - 0.83;p = 0.01)与结直肠腺瘤发生风险之间观察到具有统计学意义的负相关。

结论

我们的初步研究数据表明,COX-2基因的等位基因变异显著影响非裔美国人群中腺瘤发生的风险。

相似文献

2
Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.
Clin Transl Sci. 2012 Feb;5(1):60-4. doi: 10.1111/j.1752-8062.2011.00373.x. Epub 2012 Jan 10.
3
Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
Int J Colorectal Dis. 2009 Jun;24(6):647-54. doi: 10.1007/s00384-009-0656-8. Epub 2009 Feb 11.
4
Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Cancer Sci. 2008 Mar;99(3):576-81. doi: 10.1111/j.1349-7006.2007.00711.x. Epub 2007 Dec 19.
6
Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2726-33. doi: 10.1158/1055-9965.EPI-09-0363. Epub 2009 Sep 15.
9
Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54. doi: 10.1158/1055-9965.EPI-07-2947.

引用本文的文献

1
MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.
Cancer Med. 2019 Dec;8(17):7477-7499. doi: 10.1002/cam4.2600. Epub 2019 Oct 21.
3
Genetic Basis for Colorectal Cancer Disparities.
Curr Colorectal Cancer Rep. 2015 Dec 1;11(6):408-413. doi: 10.1007/s11888-015-0302-5. Epub 2015 Nov 11.
4
Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.
Clin Transl Sci. 2012 Feb;5(1):60-4. doi: 10.1111/j.1752-8062.2011.00373.x. Epub 2012 Jan 10.
5
Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.
Pharmacogenomics J. 2011 Oct;11(5):337-47. doi: 10.1038/tpj.2010.49. Epub 2010 Jun 15.
6
Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2726-33. doi: 10.1158/1055-9965.EPI-09-0363. Epub 2009 Sep 15.

本文引用的文献

1
Racial disparities in colorectal cancer.
Curr Probl Cancer. 2007 May-Jun;31(3):123-33. doi: 10.1016/j.currproblcancer.2007.01.002.
2
Cancer statistics, 2007.
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
4
Celecoxib for the prevention of colorectal adenomatous polyps.
N Engl J Med. 2006 Aug 31;355(9):885-95. doi: 10.1056/NEJMoa061652.
5
Celecoxib for the prevention of sporadic colorectal adenomas.
N Engl J Med. 2006 Aug 31;355(9):873-84. doi: 10.1056/NEJMoa061355.
7
Inflammation-related gene polymorphisms and colorectal adenoma.
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1126-31. doi: 10.1158/1055-9965.EPI-06-0042.
9
Genetic variation in the COX-2 gene and the association with prostate cancer risk.
Int J Cancer. 2006 Aug 1;119(3):668-72. doi: 10.1002/ijc.21864.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验